NCT01082302View on ClinicalTrials.gov

Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Genital WartsPerianal Warts
Interventions
DRUG

Polyphenon E (Veregen) 15% ointment

3 times daily application on genital and perianal warts over 7 days

OTHER

Green Tea Beverage with defined catechin content

3 times daily oral intake over 7 days

Trial Locations (1)

D-10117

Charité Research Organisation, Berlin

Sponsors

Lead Sponsor

MediGene
All Listed Sponsors
collaborator

Charité Research Organisation GmbH

OTHER

lead

MediGene

INDUSTRY